Literature DB >> 15888755

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.

L M Jost1, R A Stahel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888755     DOI: 10.1093/annonc/mdi814

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Bone involvement in patients with lymphoma: the role of FDG-PET/CT.

Authors:  Niklaus G Schaefer; Klaus Strobel; Christian Taverna; Thomas F Hany
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-22       Impact factor: 9.236

2.  Nodular lymphocyte-predominant Hodgkin lymphoma.

Authors:  Michael Fuchs; Dennis A Eichenauer; Lucia Nogová; Volker Diehl; Andreas Engert
Journal:  Curr Hematol Malig Rep       Date:  2008-07       Impact factor: 3.952

3.  Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma.

Authors:  Jean François Grellier; Laetitia Vercellino; Thierry Leblanc; Pascal Merlet; Catherine Thieblemont; Pierre Weinmann; Marie-Elisabeth Toubert; Nathalie Berenger; Josette Brière; Pauline Brice
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-26       Impact factor: 9.236

4.  The Clinical Utility of FDG PET-CT in Evaluation of Bone Marrow Involvement by Lymphoma.

Authors:  Ho Young Kim; Ju-Seok Kim; Dae Ro Choi; Hyeong Su Kim; Jung Hye Kwon; Geun-Doo Jang; Jung Han Kim; Joo Young Jung; Hun Ho Song; Young Kyung Lee; Soo Kee Min; Hee Sung Hwang; Hwa Jung Kim; Dae Young Zang; Hyo Jung Kim
Journal:  Cancer Res Treat       Date:  2014-11-24       Impact factor: 4.679

5.  Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases

Authors:  Mahmut Büyükşimşek; İrem Kolsuz; Abdullah Evren Yetişir; Mert Tohumcuoğlu; Ali Oğul; Cem Mirili; Semra Paydaş; İsa Burak Güney
Journal:  Turk J Haematol       Date:  2020-01-31       Impact factor: 1.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.